Concepedia

Mark J. Rumbak

MJ

26

Publications

3K

Citations

20

H-Index

1986

Active since

Affiliations

University of South Florida(Current)

Florida College

University of Tennessee Health Science Center

University of Tennessee at Knoxville

Tampa General Hospital

Mark J. Rumbak is an author at University of South Florida specializing in medicine, pulmonary medicine, and anesthesiology.

Top concepts

Publications per year

1986–2019

26

Publications

26

A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients*

Mark J. Rumbak, Michael Newton, Thomas Truncale et al. · Critical Care Medicine · 2004 · 754 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · PubMed · 1998 · 628 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

Edward Abraham, Antonio Anzueto, Guillermo Gutiérrez et al. · The Lancet · 1998 · 497 citations

, , +6

Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial

Gerard J. Criner, Antoine Delage, Kirk Voelker et al. · American Journal of Respiratory and Critical Care Medicine · 2019 · 169 citations · Full text

Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome

Edward Abraham, Robert P. Baughman, Eugene C. Fletcher et al. · Critical Care Medicine · 1999 · 146 citations

Rows per page

1–5 of 26